According to stock market observers, shares of the company are available at a premium of ₹242 in the grey market today ...

Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of ...

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024.

The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 13.93x ...

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.38 ...

Senores Pharmaceuticals IPO sees high demand; allocation on Dec 26, GMP suggests strong listing. Stay informed!

Here is a step-by-step guide to check your allotment status for Senores Pharma IPO via the registrar's website: ...

After finalising the share allotment status, the company will initiate refunds and transfer of shares to the demat accounts ...

Senores Pharmaceuticals IPO sees robust demand, with potential listing gain of 59%, scheduled to list on BSE and NSE.

Analysts have recommended investors subscribe to the issue, citing attractive valuations and strong demand for ...

The ongoing offers are expected to list at a premium of as much as 77% over the IPO price. Check their grey market premiums ...

The IPO comprises a fresh issue of shares worth Rs 500 crore and an offer-for-sale (OFS) of up to 21,00,000 equity shares by ...